Form 8-K AMEDISYS INC For: Aug 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UPDATE: Amedisys (AMED) Reports In-Line EPS, Revenue Tops Views; CFO to Retire
August 2, 2016 5:19 PM EDT(Updated - August 2, 2016 5:47 PM EDT)
(Update corrects for adjusted EPS figure)
Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.42 vs consensus of $0.42. Revenue for the quarter came in at $360 million versus the consensus estimate of $353.07 million.
Executive Retirement
On August 2, 2016, Ronald A. LaBorde, the Vice Chairman and... More
